(3S,4R)-3-Hydroxy-2,2-dimethyl-4-(4-methyl-2-phenylimidazol-1-yl)-chroman-6-carbonitrile

ID: ALA461800

PubChem CID: 44564205

Max Phase: Preclinical

Molecular Formula: C22H21N3O2

Molecular Weight: 359.43

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1cn([C@@H]2c3cc(C#N)ccc3OC(C)(C)[C@H]2O)c(-c2ccccc2)n1

Standard InChI:  InChI=1S/C22H21N3O2/c1-14-13-25(21(24-14)16-7-5-4-6-8-16)19-17-11-15(12-23)9-10-18(17)27-22(2,3)20(19)26/h4-11,13,19-20,26H,1-3H3/t19-,20+/m1/s1

Standard InChI Key:  YMPLHFGZNFZQLU-UXHICEINSA-N

Molfile:  

     RDKit          2D

 27 30  0  0  0  0  0  0  0  0999 V2000
   -3.6809   -6.8171    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6821   -7.6446    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9671   -8.0575    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9689   -6.4044    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2536   -6.8135    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2548   -7.6467    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5378   -8.0619    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8151   -7.6487    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8139   -6.8156    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5354   -6.3957    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4083   -8.3589    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1042   -7.2298    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0983   -6.4048    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5353   -5.5706    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3949   -6.4053    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1096   -5.9930    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8695   -5.0878    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1244   -4.3030    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9496   -4.3030    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2044   -5.0877    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0458   -5.0837    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3676   -5.7973    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1905   -5.7936    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5996   -5.0778    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1799   -4.3641    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3584   -4.3713    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4345   -3.6356    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  3  6  2  0
 10 14  1  1
  1  2  2  0
  5  4  2  0
 15 16  3  0
  1 15  1  0
 14 17  1  0
  4  1  1  0
  5 10  1  0
  6  7  1  0
  7  8  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 14  1  0
  8  9  1  0
 17 21  1  0
  9 10  1  0
 21 22  2  0
  5  6  1  0
 22 23  1  0
  8 11  1  0
 23 24  2  0
 24 25  1  0
  8 12  1  0
 25 26  2  0
 26 21  1  0
  2  3  1  0
  9 13  1  6
 19 27  1  0
M  END

Associated Targets(Human)

ABCC9 Tclin Sulfonylurea receptor 2 (109 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 359.43Molecular Weight (Monoisotopic): 359.1634AlogP: 3.85#Rotatable Bonds: 2
Polar Surface Area: 71.07Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 13.18CX Basic pKa: 5.63CX LogP: 3.61CX LogD: 3.61
Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.75Np Likeness Score: -0.26

References

1. Zhang X, Qiu Y, Li X, Bhattacharjee S, Woods M, Kraft P, Lundeen SG, Sui Z..  (2009)  Discovery and structure-activity relationships of a novel series of benzopyran-based K(ATP) openers for urge urinary incontinence.,  17  (2): [PMID:19101153] [10.1016/j.bmc.2008.11.055]

Source